Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Epstein-Barr Virus Infections × ruxolitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Primary Myelofibrosis 36 Myeloproliferative Disorders 29 Polycythemia Vera 21 Leukemia, Myeloid, Acute 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Leukemia 15 Myelodysplastic Syndromes 13 Thrombocythemia, Essential 12 Multiple Myeloma 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Breast Neoplasms 8 Recurrence 7 Neoplasms 7 Myelodysplastic-Myeloproliferative Diseases 7 Leukemia, Myelomonocytic, Chronic 7 Graft vs Host Disease 7 Pancreatic Neoplasms 6 Hematologic Neoplasms 6 Prostatic Neoplasms 5 Lymphoma, Non-Hodgkin 5 Lymphoma 5 Leukemia, Myeloid, Chronic-Phase 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Hodgkin Disease 5 Hematologic Diseases 5 Thrombocytosis 4 Carcinoma, Non-Small-Cell Lung 4 Bone Marrow Diseases 4 Triple Negative Breast Neoplasms 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Valganciclovir 6 Rituximab 6 Etoposide 4 Doxorubicin 4 Valacyclovir 3 Gemcitabine 3 Dexamethasone 3 Cyclophosphamide 3 Cisplatin 3 spartalizumab 2 pembrolizumab 2 pegaspargase 2 Zidovudine 2 Vincristine 2 Radiotherapy, Intensity-Modulated 2 Prednisone 2 Methylprednisolone 2 Methotrexate 2 Matrix-M 2 Leucovorin 2 Lenalidomide 2 Cell Count 2 Carboplatin 2 Blood Specimen Collection 2 Acyclovir 2 toripalimab 1 threonic acid 1 ruxolitinib 1 pomalidomide 1 otelixizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05039580 2021-09-09

SEHC

The First Affiliated Hospital of Soochow University

Phase 4 Unknown

Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡